Summer 2021 EIPM External Newsletter
July 12, 2021
July 2021
Dear Friend of the Englander Institute for Precision Medicine,
What you’ll find in medicine cabinets in 2030
July 12, 2021
The modern medicine cabinet is filled with all sorts of things, from pain relievers and birth control pills to antibiotics and bandages.
New Research on How Tumors Evolve to Become Aggressive
July 8, 2021
Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer
Single-cell RNA sequencing of prostate cells from mice with alterations in Pten, RB1 and MYCN identified 10 major cell subtypes and enabled researchers to study tumor heterogeneity with unprecedented resolution. Credit: Dr. Nicholas Brady.
New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine
July 5, 2021
Cheryl Bonder had been living with a vaguely defined blood malignancy for years when her prognosis rapidly took a turn for the worse: her condition was progressing toward acute myelogenous leukemia (AML), an aggressive cancer of the blood and bone marrow. “I was going south pretty quickly without another good plan in place,” recalls Bonder, a 61 year old health and wellness coach from New Jersey. Traditional chemotherapy might have offered her a few more months, but that was not how she wanted her life to end.
Juneteenth and the Promise of Medical Equity
June 17, 2021
The enormous promise of precision medicine to advance science and speed new, highly targeted therapies to patients is exceeded only by its potential to achieve something even more important: To help bring equity to medicine.
EIPM: Combination Therapy Boosts Response, Cuts Treatment Time
June 15, 2021
Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer led by Weill Cornell Medicine and NewYork-Presbyterian investigators. In view of the safety and efficacy of the treatment, a larger trial is warranted.
Breast Cancer Risk in African Americans Tied to Genetic Variations
June 14, 2021
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The study findings may have implications for developing better risk assessment tools for TNBC in African American women and for understanding why they have poorer TNBC outcomes.
EIPM Researcher Wins Pershing Square Sohn Prize
June 1, 2021
Dr. Marcin Imielinski, an assistant professor of pathology and laboratory medicine [and a Member of the Englander Institute for Precision Medicine], and Dr.
EIPM Director’s June 2021 Newsletter
June 1, 2021
Dear Members of the Englander Institute,
I hope you enjoy this month’s newsletter, which is packed with a remarkable number of news stories about the work of our colleagues, their awards, events and publications. I’m so proud of these achievements, and I hope you are as well.
I’d like to welcome the newest member of our team, computational biologist Peter Waltman, Ph.D., who will be working in my lab and in the lab of Dr. Andrea Sboner, our Director of Informatics and Computational Biology.